Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 607
Filter
6.
Tex Med ; 116(4): 4, 2020 Apr 01.
Article in English | MEDLINE | ID: mdl-32353154

ABSTRACT

We are pleased to announce the debut of the House of Delegates Online Testimony page on the TMA website.


Subject(s)
Administrative Personnel , Advisory Committees , Committee Membership , Policy Making , Societies, Medical/legislation & jurisprudence , Societies, Medical/organization & administration , Humans , Texas
7.
Endocrinol. diabetes nutr. (Ed. impr.) ; 67(1): 61-69, ene. 2020. tab
Article in Spanish | IBECS | ID: ibc-186148

ABSTRACT

Aunque la nutrición de yodo en España ha mejorado en los últimos años, el problema no está resuelto del todo. Es preciso que las Instituciones sanitarias establezcan medidas para garantizar que la nutrición de yodo de toda la población sea la adecuada, especialmente entre los colectivos de mayor riesgo (niños y adolescentes, mujeres en edad fértil, mujeres embarazadas y madres lactantes). Debe aconsejarse un bajo consumo de sal, pero que esta sea yodada. También es imprescindible que las agencias de control alimentario establezcan un control efectivo sobre una adecuada yodación de la sal. En las futuras encuestas de salud debería incluirse indicadores sobre la nutrición de yodo. El estudio EUthyroid y la Declaración de Cracovia sobre la nutrición de yodo brindan una oportunidad para establecer un plan paneuropeo para la prevención de la deficiencia de yodo que debería ser considerada y aprovechada por las autoridades sanitarias


Although iodine nutrition in Spain has improved in recent years, the problem is not completely resolved. It is necessary that health institutions establish measures to ensure an adequate iodine nutrition of the population, especially among the highest risk groups (children and adolescents, women of childbearing age, pregnant women and nursing mothers). A low salt intake should be advised, but it should be iodized. It is also imperative that food control agencies establish effective control over adequate iodization of salt. Indicators on iodine nutrition should be included in future health surveys. The EUthyroid study and the Krakow Declaration on iodine nutrition provide an opportunity to set up a pan-European plan for the prevention of iodine deficiency that should be considered and used by health authorities


Subject(s)
Humans , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Iodine Compounds/therapeutic use , Iodine Deficiency/prevention & control , Nutritive Value , Iodine/administration & dosage , Iodine/metabolism , Breast Feeding , Diet, Sodium-Restricted , Health Planning/legislation & jurisprudence , Societies, Medical/legislation & jurisprudence , Societies, Medical/standards , Public Health/legislation & jurisprudence , Public Health/standards
8.
Ann R Coll Surg Engl ; 102(2): 144-148, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31755728

ABSTRACT

INTRODUCTION: Statutory duty of candour was introduced in November 2014 for NHS bodies in England. Contained within the regulation were definitions regarding the threshold for what constitutes a notifiable patient safety incident. However, it can be difficult to determine when the process should be implemented. The aim of this survey was to evaluate the interpretation of these definitions by British neurosurgeons. MATERIALS AND METHODS: All full (consultant) members of the Society of British Neurological Surgeons were electronically invited to participate in an online survey. Surgeons were presented with 15 cases and asked to decide in the case of each one whether they would trigger the process of duty of candour. Cases were stratified according to their likelihood and severity. RESULTS: In all, 106/357 (29.7%) members participated in the survey. Responses varied widely, with almost no members triggering the process of duty of candour in cases where adverse events were common (greater than 10% likelihood) and required only outpatient follow-up (7/106; 6.6%), and almost all members doing so in cases where adverse events were rare (less than 0.1% likelihood) and resulted in death (102/106; 96.2%). However, there was clear equipoise in triggering the process of duty of candour in cases where adverse events were uncommon (0.1-10% likelihood) and resulted in moderate harm (38/106; 35.8%), severe harm (57/106; 53.8%) or death (49/106; 46.2%). CONCLUSION: There is considerable nationwide variation in the interpretation of definitions regarding the threshold for duty of candour. To this end, we propose a framework for the improved application of duty of candour in clinical practice.


Subject(s)
Neurosurgical Procedures/adverse effects , Patient Safety/legislation & jurisprudence , Quality of Health Care/legislation & jurisprudence , State Medicine/organization & administration , Cross-Sectional Studies , England , Health Plan Implementation , Humans , Medical Errors/legislation & jurisprudence , Medical Errors/prevention & control , Neurosurgeons/legislation & jurisprudence , Neurosurgeons/statistics & numerical data , Neurosurgery/legislation & jurisprudence , Neurosurgery/organization & administration , Physician-Patient Relations , Societies, Medical/legislation & jurisprudence , Societies, Medical/organization & administration , State Medicine/legislation & jurisprudence , Surveys and Questionnaires/statistics & numerical data
9.
Cuad. bioét ; 30(100): 303-313, sept.-dic. 2019.
Article in Spanish | IBECS | ID: ibc-185243

ABSTRACT

El derecho a la información clínica y el consentimiento informado como expresión práctica del principio de autonomía, son conquistas legales en España de finales del siglo XX que se han trasladado a la normativa deontológica médica. Se estudia el ritmo de ese traslado. Revisión histórica de los diferentes códigos de deontología médica desde la Guerra Civil, buscando la presencia de estas ideas en ella. Hasta el código de 1979 la idea de información clínica no aparece en la normativa deontológica vigente y el consentimiento lo hace en casos muy restringidos. A partir de esa fecha su aparición es progresiva en los sucesivos códigos. Actualmente ambas ideas están completamente desarrolladas en la normativa deontológica española. La Deontología médica ha asumido como suyas las ideas de información al paciente y consentimiento in-formado. Este ha sido un proceso largo en el tiempo que ha cambiado en buena medida la orientación deontológica para las relaciones médico-enfermo. En estos aspectos, la Deontología médica pasa, de hacer hincapié en la prudencia del médico, a subrayar el deber de informar y de dar amplio espacio a las decisiones del paciente, al que reconoce como un agente moral autónomo y reflexivo, capaz de tomar sus propias decisiones sobre su salud


In Spain, the right to clinical information and informed consent as a practical expression of the principle of autonomy, are legal conquests achieved in the late twentieth century. From the law they have been transferred to the codes of medical deontology. The aim of this work is to study the pace of this transfer. Historical review of the different codes of medical deontology in Spain since the Civil War, see-king the presence of these ideas in them. Until code of medical deontology of 1979, the idea of clinical information did not appear in the contemporary deontological norm, and the rules on consent did so in very restricted cases. As of that date, their appearance is progressive in the successive codes. Currently, both concepts are fully developed in Spanish deontological regulations. Medical Deontology has take on the ideas of patient information and informed consent. This has been a long process which have brought considerable changes the deontological orientations of the traditional form of doctor-patient relationship. In these aspects, medical deontology has drifted, from emphasizing the prudence of the doctor, to emphasize the duty to inform and give ample space to the patient’s decisions, which he recognizes as an autonomous and reflective moral agent, capable of taking his own decisions about your health


Subject(s)
Humans , History, 20th Century , Health Information Systems/ethics , Health Information Systems/legislation & jurisprudence , Informed Consent/ethics , Ethical Theory , Societies, Medical/ethics , Ethics, Clinical , Informed Consent/legislation & jurisprudence , Codes of Ethics/legislation & jurisprudence , Codes of Ethics/trends , Societies, Medical/legislation & jurisprudence
10.
J BUON ; 24(4): 1314-1325, 2019.
Article in English | MEDLINE | ID: mdl-31646774

ABSTRACT

PURPOSE: Internet fake information, parapharmacy and counterfeit drugs are a market of hundreds of billion dollars. Misleading internet data decrease patients' compliance to medical care, promote use of questionable and detrimental practices, and jeopardize patient outcome. This is particularly harmful among cancer patients, especially when pain and nutritional aspects are considered. Provision of Web recommendations for the general audience (patients, relatives, general population) from official medical-providers might be useful to outweigh the detrimental internet information produced by non-medical providers. METHODS: 370 oncology and anesthesiology related societies were analyzed. Our objective was to evaluate the magnitude of web-recommendation for cancer cachexia and cancer pain for the general audience provided by official medical organizations' web sites at global level. RESULTS: Magnitude of web-recommendations at global level was surprisingly scant both for coverage and consistency. Seven official medical societies provided updated web-recommendation for cancer cachexia to their patients/family members, and 15 for cancer pain. Scantiness was unrelated by continent, developmental index, oncology tradition, economic-geographic area and society type scrutinized. CONCLUSIONS: Patients need expert advice when exposed to fake internet information largely dominated by paramedical market profits. In this era of "new media" the patients' net-education represents a new major educational challenge for medical societies.


Subject(s)
Cachexia/epidemiology , Internet , Neoplasms/epidemiology , Anesthesiology/legislation & jurisprudence , Anesthesiology/standards , Cachexia/drug therapy , Counterfeit Drugs , Humans , Medical Oncology/legislation & jurisprudence , Neoplasms/drug therapy , Patients/legislation & jurisprudence , Societies, Medical/legislation & jurisprudence , Societies, Medical/standards
11.
G Ital Nefrol ; 36(5)2019 Sep 24.
Article in Italian | MEDLINE | ID: mdl-31580540

ABSTRACT

According to the new Clinical Guidelines National Plan, Scientific Societies take on a key role in creating and implementing guidelines within the National Health System. We chart the efforts of our Society in creating the right kind of expertise and closing the gap with Scientific Societies abroad.


Subject(s)
Clinical Decision-Making , Conflict of Interest , Evidence-Based Medicine/standards , Nephrology , Practice Guidelines as Topic/standards , Societies, Medical , International Cooperation , Italy , Societies, Medical/legislation & jurisprudence
15.
Circ J ; 83(9): 1819-1821, 2019 08 23.
Article in English | MEDLINE | ID: mdl-31391350

ABSTRACT

Heart failure pandemic is rapidly approaching in Japan, requiring nationwide actions. In particular, the Japanese Circulation Society and related societies launched the Stroke and Cardiovascular Disease Control Act, which was passed by the National Diet, as the first ever legislative policy measure against stroke and cardiovascular disease. In association with this, actions against heart failure pandemic from the scientific field are also important. Because heart failure pandemic is a critical problem not only in Japan but also in many developed countries, we believe the nationwide approach, as summarized here, will greatly contribute to the development of cardiovascular medicine, particularly the management and treatment of heart failure worldwide.


Subject(s)
Delivery of Health Care, Integrated/legislation & jurisprudence , Health Policy , Heart Failure/therapy , Pandemics , Policy Making , Societies, Medical/legislation & jurisprudence , Societies, Scientific/legislation & jurisprudence , Biomedical Research/legislation & jurisprudence , Health Services Needs and Demand/legislation & jurisprudence , Heart Failure/diagnosis , Heart Failure/epidemiology , Humans , Japan/epidemiology , Needs Assessment/legislation & jurisprudence , Preventive Health Services/legislation & jurisprudence , Risk Factors
17.
J Pediatr Surg ; 54(7): 1269-1276, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31079862

ABSTRACT

Firearm injuries are the second most common cause of death in children who come to a trauma center, and pediatric surgeons provide crucial care for these patients. The American Pediatric Surgical Association (APSA) is committed to comprehensive pediatric trauma readiness, including firearm injury prevention. APSA supports a public health approach to firearm injury, and it supports availability of quality mental health services. APSA endorses policies for universal background checks, restrictions on assault weapons and high capacity magazines, strong child access protection laws, and a minimum purchase age of 21 years. APSA opposes efforts to keep physicians from counseling children and families about firearms. APSA promotes research to address this problem, including increased federal research support and research into the second victim phenomenon. APSA supports school safety and readiness, including bleeding control training. While it may be daunting to try to reduce firearm deaths in children, the U.S. has seen success in reducing motor vehicle deaths through a multidimensional approach - prevention, design, policy, behavior, trauma care. APSA believes that a similar public health approach can succeed to save children from death and injury from firearms. APSA is committed to building partnerships to accomplish this. TYPE OF STUDY: APSA Position Statement. LEVEL OF EVIDENCE: Level V, Expert Opinion.


Subject(s)
Crime Victims/statistics & numerical data , Firearms , Mental Health Services/organization & administration , Schools/organization & administration , Societies, Medical/legislation & jurisprudence , Wounds, Gunshot/prevention & control , Child , Firearms/legislation & jurisprudence , Humans , Public Policy , Trauma Centers , United States/epidemiology , Wounds, Gunshot/epidemiology
18.
Plast Reconstr Surg ; 143(5): 1533-1539, 2019 05.
Article in English | MEDLINE | ID: mdl-31033838

ABSTRACT

Similar to the outcry over the ethics of website marketing by physicians in the 1990s, the resistance to plastic surgeons' use of social media has been loud and vehement. Many physicians, although receptive to website marketing, view social media as too radical or unprofessional. Despite the controversy, the value of social media as a communication tool for interacting with and educating patients is supported by studies showing that 65 percent of Americans and 90 percent of young adults use social media. Many plastic surgeons have been early adopters, as reflected by the articles written to help board-certified plastic surgeons use social media in academic medicine and for their practice. However, there is little guidance for young plastic surgeons who wish to use social media for professional purposes. In this study, the authors discuss the ethics and current literature on social media use by young plastic surgeons and make recommendations for how to use social media during training and after residency graduation.


Subject(s)
Marketing of Health Services/ethics , Social Media/statistics & numerical data , Surgeons/ethics , Surgery, Plastic/ethics , Humans , Marketing of Health Services/legislation & jurisprudence , Marketing of Health Services/standards , Marketing of Health Services/statistics & numerical data , Practice Guidelines as Topic , Social Media/ethics , Societies, Medical/legislation & jurisprudence , Societies, Medical/standards , Surgeons/statistics & numerical data , Surgery, Plastic/legislation & jurisprudence , Surgery, Plastic/standards , Surgery, Plastic/statistics & numerical data , United States , United States Federal Trade Commission/legislation & jurisprudence
20.
Bol. pediatr ; 59(250): 270-276, 2019. tab, graf
Article in Spanish | IBECS | ID: ibc-195028

ABSTRACT

La investigación en Pediatría es esencial para el bienestar de la población infantil y de su futuro como adultos. Su importancia está fuera de toda duda y debemos abogar por una investigación ética y legalmente intachable que proporcione conocimientos y evidencia científica de calidad. En todas las sociedades científicas pediátricas se busca fomentar esta investigación entre sus socios, sobre todo los más jóvenes, y nuestra Sociedad de Pediatría de Asturias, Cantabria, Castilla y León no debería quedarse al margen. En los últimos años se ha producido gran cantidad de textos y legislación en el tema de la ética en investigación en clínica humana, tanto a nivel internacional como nacional. En este artículo de revisión intentaré ordenar y poner al día los aspectos más importantes de este problema y discutir concretamente los referentes a la edad pediátrica, como población vulnerable. Por último, plantearé el problema de la confidencialidad de los datos en los estudios observacionales y otros aspectos a tener en cuenta de cara al futuro de la ética en la investigación pediátrica


Pediatric research is essential for the well-being of children and their future as adults. The importance of this research is beyond doubt and we must advocate for an ethically and legally flawless research that provides knowledge and quality scientific evidence. In all the pediatric scientific societies it is sought to promote this research among its partners, especially the youngest, and our Pediatric Society of Asturias, Cantabria, Castilla y León should not be left out. In recent years there has been a large number of texts and legislation on the subject of ethics in human clinical research, both internationally and nationally. In this review article I will try to organize and update the most important aspects of this problem and specifically discuss those referring to pediatric age, as a vulnerable population. Finally, I will raise the problem of confidentiality of data in observational studies and other aspects to consider in the future of ethics in pediatric research


Subject(s)
Humans , Child , History, 20th Century , Pediatrics/ethics , Pediatrics/legislation & jurisprudence , Ethics, Research , Child Welfare/ethics , Confidentiality/ethics , Confidentiality/legislation & jurisprudence , Pediatrics/history , Child Welfare/legislation & jurisprudence , Societies, Medical/ethics , Societies, Medical/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL